Mr David Fueller

Emory Clinical Cardiovascular Research Institute, Atlanta (United States of America)

Follow

Contributor content

Soluble urokinase Plasminogen Activator Receptor (suPAR) is associated with educational attainment in patients with coronary artery disease

Presentation

Soluble urokinase Plasminogen Activator Receptor (suPAR) is associated with educational attainment in patients with coronary artery disease

ESC 365 is supported by

novartis

Explore sponsored resources